Clinical Trial Update: Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)

View source ↗

Summary

A clinical trial update for the CORSAR study in Russia, sponsored by AstraZeneca, examining clinical and demographic features of patients with uncontrolled seve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: AstraZeneca | Conditions: Severe Asthma | Status: RECRUITING